Reuters Health Report

Click to View in Browser 04/17/2014 GSK, facing bribery claims, battles to build new sales model LONDON (Reuters) - Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices. Reports of e-cigarette injury jump amid rising popularity, U.S. data show WASHINGTON (Reuters) - Complaints of injury linked to e-cigarettes, from burns and nicotine toxicity to respiratory and cardiovascular problems, have jumped over the past year as the devices become more popular, the most recent U.S. data show. Teva, Pfizer settle patent lawsuit over blockbuster painkiller (Reuters) - Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December. China backs away from price controls on basic drugs BEIJING/SHANGHAI (Reuters) - China has backtracked on its policy of capping retail prices on medicines and will allow pharmaceutical companies to set prices for some drugs, after criticism that controls had caused a drug drought that derailed treatment for millions of patients. Death toll from Guinea Ebola outbreak rises to 122 CONAKRY (Reuters) - The death toll from an Ebola outbreak in Guinea has risen to 122, the World Health Organisation said on Thursday, a sharp increase from a previous figure of 108. Founder of scandal-hit drugmaker Servier dies at 92 PARIS (Reuters) - Jacques Servier, founder and president of France's second-largest drugmaker, has died before his trial over Mediator, a weight-loss pill at the center of the country's biggest public health scandal in years. Galapagos, GSK successfully conclude phase 2a study of skin disease drug BRUSSELS (Reuters) - Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC. California makes it harder for insurers to deny autism treatment SACRAMENTO, California (Reuters) - California on Wednesday made it harder for health insurers to deny or delay coverage of key interventions for children with autism, the latest in an ongoing series of actions by U.S. states to help families obtain the expensive therapies. British consumer watchdog to test for lamb meat substitution (Reuters) - Britain's Foods Standards Agency (FSA) said it will begin a new round of tests on lamb takeaway meals from restaurants across the UK after the consumer watchdog found evidence of cheaper substitutes such as beef and chicken. New kind of trial aims to speed cancer drug development LONDON (Reuters) - Scientists and drugmakers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of bringing them to market. Related Video Titan Aerospace a sky-high platform for Google's internet ambitions Rubbee set to electrify cycling The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend